Dr Galbraith is Senior Vice President and Head of Oncology Innovative Medicines at AstraZeneca, and Susan Searle is co-founder and ex-CEO of Imperial Innovations Group. Both join Horizon with immediate effect.
Horizon Discovery appoints Dr Susan Galbraith and Susan Searle as Non-Executive Directors
Dr Galbraith is Senior Vice President and Head of Oncology Innovative Medicines at AstraZeneca, and Susan Searle is co-founder and ex-CEO of Imperial Innovations Group. Both join Horizon with immediate effect.
Tags
Related posts
- New clinical trial aims to investigate skin patches to spot lung transplant rejection
- CureVac and MD Anderson Cancer Center partner to develop new cancer vaccines
- Researchers introduce new AI tool to help clinicians capture uncertainty in medical images
- New UK report highlights inequalities among people living with breast cancer
- ELRIG UK and SRG collaborate to advance life sciences professionals in drug discovery
